JULY 1982 - VOLUME 3 - NUMBER 7
Reagan to U.S. Exporters: Dump AwayNew hazards policy in the offingby S. Jacob ScherrU.S. Secretary of Commerce Malcolm Baldrige and Secretary of State Alexander Haig recently submitted a report to President Reagan which calls for a relaxation of existing U.S. controls on exports of banned substances. If enacted, the Baldrige-Haig proposal would make it easier for U.S. chemical and pharmaceutical companies to "dump" banned or dangerous, unapproved products upon unsuspecting foreign customers, particularly in the Third World. The Baldrige-Haig proposal recommends two fundamental changes in U.S. hazardous export policy:
The 14-page report, recently released to the press, is heavy on ideological rhetoric and extremely short on the facts. It asserts without any documentation that export notifications represent "a burdensome regulatory procedure that fails to achieve its intended purpose." In support of this claim, the proposal cites only the views of the American companies that the government is supposed to regulate: "U.S. industry reports that in many cases, this procedure has proven ineffective and costly." Instead of export-specific notifications, which place the responsibility for flagging U.S.-exported hazards firmly in the hands of the U.S. government, the Baldrige-Haig report recommends a policy that would throw the difficult task of pinpointing such dangerous exports into the laps of foreign governments. The report proposes that the U.S. government inform foreign governments only about the U.S. regulations covering hazardous products in the U.S. The U.S., Baldrige and Haig maintain, should do away with notifying foreign governments of specific shipments of hazardous products by U.S. companies. Generally, the U.S. government should notify foreign governments only under two circumstances, the report says: first, whenever the U.S. changes its own regulations; and second, in an annual report which would include a list of banned, restricted, unapproved and "export only" products. The Baldrige-Haig Report devotes only a single paragraph to the controversial question of whether the United States should permit the export of drugs not approved for sale here - a practice which has been prohibited since passage of the Food, Drug and Cosmetic Act in 1938. The report states flatly that "this simply results in the importing country obtaining the product elsewhere." From this assertion flows a stream of horribles - adverse effects on U.S. balance of trade, shifting of manufacturing facilities to overseas locations, and loss of sales for individual firms without benefits to foreign customers. The recommendation in favor of exporting unapproved drugs is especially troubling. The U.S. government's long-standing policy against such exports reflects American concerns that foreign people not be used as "guinea pigs" for drugs which have not been fully tested and approved for domestic use. This is a sentiment shared by developing country leaders. At the 1980 World Health Assembly, Indian Prime Minister Indira Gandhi complained that "sometimes dangerous new drugs were tried out on populations of weaker countries although their use was prohibited within the countries of manufacture." The report's logic is almost as appalling as its insensitivity. The arguments Baldrige and Haig proffer for weakening the existing export requirements actually demonstrate the need to strengthen them. The report states, for example, that "many developing countries... lack sufficient scientific capability to use effectively the export-specific notices." But rather than draw the rational conclusion that the U.S. government - possessing greater technical capability - should take more responsibility for guarding against hazardous exports, the Baldrige-Haig proposal in effect does just the opposite: it would increase the burden on Third World countries to detect and stop proposed imports of banned substances. Another of the Haig-Baldrige excuses for changing the present regulations is that they inadequately deal with the alleged problem of the re-export of hazardous products: "none of the Acts require that hazardous substance notices be delivered to the country where the product will be used, if different from the country of first import. Thus, the intent of the Acts is thwarted when re-export occurs." If the re-export problem is a real one and the administration is truly concerned about it, it should propose legislation - analogous to that governing military sales - making it illegal for a foreign purchaser to re-export the U.S. product without appropriate notification. One last inconsistency points up the absurdity of the Baldrige-Haig proposal. The report attempts to make a distinction between "defective" consumer products and "banned" toxic chemicals and pesticides. It recommends that existing export notice procedures be retained for the former, but eliminated for the latter. This could produce a situation where the U.S. would alert a foreign government as to the proposed shipment of banned TRIS-treated baby garments, but would provide no warning as to exports of TRIS itself even if it has been banned as a toxic chemical! While the existing regulations could be improved, they have helped to prevent the export of hazardous products from the U.S. The present prohibition on the export of banned drugs has assured that the United States has not been the purveyor to the developing world of drugs, like thalidomide or clioquinol, which have already harmed public health in industrialized nations. Export notification procedures have enabled the South Koreans to reject the shipment of PCB-contaminated animal fats, the Canadians to halt the proposed import of children's lamps coated with dangerous lead-based paint, and the Greeks to stop the use of a pesticide never approved by the U.S. Environmental Protection Agency. Finally, the current policies also appear to have brought about some restraint in U.S. corporate attitudes. Proctor & Gamble used its millions of recalled Rely tampons as fuel for its factories rather than offloading them abroad. Rohm & Haas, a Philadelphia-based chemical manufacturer, has refused to sell its voluntarily-withdrawn pesticide TOK to foreign countries which lacked the capability to protect workers using their product. The Reagan Administration is now sending quite a different message to American companies stuck with inventories of banned goods. The Reagan Administration's move to dismantle the regulations on hazardous exports not only places it at odds with the previous administration's policy (see sidebar), but also with growing international acceptance of the need to control hazardous exports. In 1980, the U.N. General Assembly passed a resolution calling upon exporting nations to discourage the shipment abroad of banned products in consultation with importing countries. In 1981, at the initiative of the United States, the Organization of Economic Cooperation and Development (OECD) - whose 24 Western industrialized member countries account for the bulk of the world's chemical trade - began a study of the need for information exchange related to exports of banned chemicals. Just three months ago, the OECD expert groups, which included representatives of government agencies and chemical industries from the major chemical producing countries, agreed to a report endorsing the concept of export-specific notifications. More recently, the West German government proposed that the OECD begin work on a code of conduct concerning trade in dangerous chemical products. It is ironic that the Reagan Administration is now retreating just as other nations are beginning to follow the U.S. lead. S. Jacob Scherr is a senior staff attorney at the Natural Resources Defense Council. Patty Power, NRDC intern, assisted in the preparation of this article.
|